Abingdon Health Plc (LSE:ABDX) — Stock Price
Abingdon Health Plc (LSE:ABDX) is currently trading at GBX10.50 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX5.25 and GBX12.75. This page tracks Abingdon Health Plc's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Abingdon Health Plc.
Abingdon Health Plc (ABDX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Abingdon Health Plc's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Abingdon Health Plc Income Statement — Revenue, Profit & Earnings by Year
Abingdon Health Plc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | GBX8.43 Million | GBX6.13 Million | GBX4.04 Million | GBX2.83 Million | GBX11.62 Million |
| Cost of Revenue | GBX5.30 Million | GBX2.46 Million | GBX2.64 Million | GBX8.06 Million | GBX8.22 Million |
| Gross Profit | GBX3.13 Million | GBX3.68 Million | GBX1.40 Million | GBX-5.23 Million | GBX3.39 Million |
| Research & Development | — | — | — | GBX182.00K | GBX503.00K |
| SG&A | GBX7.71 Million | GBX5.07 Million | GBX5.22 Million | GBX6.64 Million | GBX7.55 Million |
| Total Operating Expenses | GBX7.15 Million | GBX5.05 Million | GBX5.25 Million | GBX6.88 Million | GBX8.91 Million |
| Operating Income | GBX-4.03 Million | GBX-1.37 Million | GBX-3.85 Million | GBX-12.11 Million | GBX-5.52 Million |
| EBITDA | GBX-3.12 Million | GBX-916.00K | GBX-2.81 Million | GBX-19.98 Million | GBX-6.07 Million |
| EBIT | GBX-3.73 Million | GBX-1.34 Million | GBX-3.50 Million | GBX-21.62 Million | GBX-6.82 Million |
| Interest Expense | GBX75.00K | GBX57.00K | GBX75.00K | GBX69.00K | GBX234.00K |
| Income Before Tax | GBX-3.81 Million | GBX-1.40 Million | GBX-3.57 Million | GBX-21.68 Million | GBX-6.95 Million |
| Income Tax Expense | GBX-390.00K | GBX-128.00K | GBX-105.00K | GBX-331.00K | GBX19.00K |
| Net Income | GBX-3.42 Million | GBX-1.27 Million | GBX-3.47 Million | GBX-21.26 Million | GBX-6.97 Million |
Abingdon Health Plc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Abingdon Health Plc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | GBX9.31 Million | GBX5.09 Million | GBX6.06 Million | GBX12.77 Million | GBX33.23 Million |
| Total Current Assets | GBX5.13 Million | GBX3.55 Million | GBX4.76 Million | GBX10.96 Million | GBX22.96 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | GBX2.69 Million | GBX1.08 Million | GBX1.10 Million | GBX8.34 Million | GBX10.09 Million |
| Inventory | GBX526.00K | GBX441.00K | GBX329.00K | GBX534.00K | GBX7.89 Million |
| Property, Plant & Equipment | — | — | GBX1.21 Million | GBX1.78 Million | GBX9.04 Million |
| Goodwill | GBX2.28 Million | GBX379.00K | GBX0.00 | GBX763.00K | GBX763.00K |
| Total Liabilities | GBX4.01 Million | GBX2.84 Million | GBX3.05 Million | GBX6.34 Million | GBX11.90 Million |
| Total Current Liabilities | GBX2.92 Million | GBX1.82 Million | GBX2.12 Million | GBX5.32 Million | GBX10.76 Million |
| Long-term Debt | GBX652.00K | GBX722.00K | GBX708.00K | GBX435.00K | GBX367.00K |
| Net Debt | GBX-890.00K | GBX-391.00K | GBX-2.22 Million | GBX-1.12 Million | GBX-3.48 Million |
| Total Stockholder Equity | GBX5.30 Million | GBX2.25 Million | GBX3.01 Million | GBX6.43 Million | GBX21.33 Million |
| Retained Earnings | GBX-32.17 Million | GBX-28.76 Million | GBX-27.46 Million | GBX-24.11 Million | GBX-2.97 Million |
Abingdon Health Plc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Abingdon Health Plc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-3.18 Million | GBX-1.66 Million | GBX1.00 Million | GBX-7.74 Million | GBX-12.88 Million |
| Capital Expenditures | GBX327.00K | GBX41.00K | GBX157.00K | GBX760.00K | GBX7.25 Million |
| Free Cash Flow | GBX-3.43 Million | GBX-1.70 Million | GBX845.00K | GBX-8.49 Million | GBX-20.13 Million |
| Investing Cash Flow | GBX-1.43 Million | GBX-23.00K | GBX-156.00K | GBX-760.00K | GBX-7.28 Million |
| Financing Cash Flow | GBX5.08 Million | GBX-114.00K | GBX-7.00K | GBX5.92 Million | GBX20.74 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | GBX214.00K | GBX48.00K | GBX28.00K | GBX231.00K | GBX1.37 Million |
| Depreciation | GBX608.00K | GBX426.00K | GBX673.00K | GBX1.64 Million | GBX749.00K |
| Change in Cash | GBX478.00K | GBX-1.80 Million | GBX839.00K | GBX-2.58 Million | GBX588.76K |
Abingdon Health Plc Earnings History — EPS Actual vs. Analyst Estimates
Track Abingdon Health Plc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 01, 2026 | 0.00 | 0.00 | — |
| Nov 11, 2025 | -0.89 | 0.00 | — |
| Mar 24, 2025 | -0.01 | 0.00 | — |
| Mar 31, 2023 | -0.02 | — | — |
| Nov 24, 2022 | -0.13 | — | — |
| Mar 29, 2022 | -0.02 | 0.00 | — |
| Nov 18, 2021 | -0.07 | 0.00 | — |
| Mar 09, 2021 | -0.01 | 0.00 | — |